METHOTREXATE SUBCUTANEOUS SOLUTION Canada - English - Health Canada

methotrexate subcutaneous solution

accord healthcare inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

METHOTREXATE injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

methotrexate injection, powder, lyophilized, for solution

hikma pharmaceuticals usa inc. - methotrexate (unii: yl5fz2y5u1) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection

Methotrexate 2.5 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 2.5 mg tablets

mercury pharmaceuticals ltd - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate

Methotrexate 2.5mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 2.5mg tablets

orion corporation - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate

Methotrexate 10 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 10 mg tablets

orion corporation - methotrexate - tablet - 10 milligram(s) - other immunosuppressants; methotrexate

Methotrexate 2.5mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 2.5mg tablets

morningside healthcare ltd - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate

Methotrexate 10 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 10 mg tablets

morningside healthcare ltd - methotrexate - tablet - 10 milligram(s) - other immunosuppressants; methotrexate

Methotrexate 2.5 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 2.5 mg tablets

accord healthcare limited - methotrexate - tablet - 2.5 milligram(s) - folic acid analogues; methotrexate

Methotrexate 10 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 10 mg tablets

accord healthcare limited - methotrexate - tablet - 10 milligram(s) - folic acid analogues; methotrexate

Methotrexate Orion 2.5 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate orion 2.5 mg tablets

orion corporation - methotrexate - tablet - 2.5 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate